The neurologic porphyrias are a group of four clinically related disor
ders, each caused by deficiency of a different enzyme of heme synthesi
s. Conventional biochemical testing for these disorders is based on th
e analysis of porphyrins and their precursors in urine and feces. The
complementary DNA sequence and gene organization of all four enzymes h
ave now been determined, and this information has laid the foundation
for molecular testing. More than 60 mutations causing acute intermitte
nt porphyria have been reported, and mutations causing hereditary copr
oporphyria, variegate porphyria and ALA dehydratase deficiency have be
en described as well. Ln families with a known mutation, DNA-based tes
ting offers greater accuracy than traditional biochemical tests in ide
ntifying or excluding gene carriers.